AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2021
Committee Review
May 2021
Senate Passage
May 2021
House Passage
Governor
Introduced Feb 17, 2021
Last action May 27, 2021
Floor votes · Senate May 26, 2021
How they voted
23–11
Passed · 2 other
Total votes 36
May 26, 2021
D
Democratic24
91% Yea
R
Republican12
91% Nay
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
24
Key actions
1
Committee
9
May 26, 2021
Senate · Passed
SENATE PASSED
May 18, 2021
Senate · Referred to committee
NO NEW FILE BY COMM. ON Appropriations
May 18, 2021
Senate · Introduced
FILED WITH LCO
May 17, 2021
Senate · Reported by committee
Joint Favorable
May 12, 2021
Senate · Referred to committee
REF. BY SEN. TO COMM. ON Appropriations
May 4, 2021
Senate · Referred to committee
NO NEW FILE BY COMM. ON Judiciary
May 4, 2021
Senate · Introduced
FILED WITH LCO
May 3, 2021
Senate · Reported by committee
Joint Favorable
Apr 28, 2021
Senate · Referred to committee
REF. BY SEN. TO COMM. ON Judiciary
Feb 26, 2021
Senate · Referred to committee
REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 03/03/21
Feb 17, 2021
Senate · Introduced
FILED WITH LCO
Feb 16, 2021
Senate · Reported by committee
Joint Favorable
Jan 22, 2021
Senate · Referred to committee
REF. TO JOINT COMM. ON General Law
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Martin Looney
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 262
Scope: CT
Hi! I can help you understand SB 262. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline